Novo Nordisk A/S The four-year expansion will focus on childhood overweight and obesity prevention for over 80 million children across seven priority countries: Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya Novo will commit USD 18 million from 2026 to 2030. The four-year programme will run from 2027 to 2030, while funding begins in 2026 to support programme inception and preparation Childhood obesity has surpassed underweight globally for the first time on record.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.